Skip to main content

CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2024 Results

Allentown, PA, Feb. 26, 2025 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2024 ResultsReported Fourth Quarter 2024 Net Income of $16.9 million, Adjusted EBITDA of $35.5 million and Distributable Cash Flow of $21.1 million compared to Fourth Quarter 2023 Net Income of $16.7 million, Adjusted EBITDA of $47.6 million and Distributable Cash Flow of $35.8 million Generated Full Year 2024 Net Income of $22.5 million, Adjusted EBITDA of $145.5 million and Distributable Cash Flow of $86.0 million compared to Full Year 2023 Net Income of $42.6 million, Adjusted EBITDA of $165.8 million and Distributable Cash Flow of $116.7 million Reported Fourth Quarter 2024 Gross Profit for the Retail Segment of $75.1 million compared to $69.0 million of Gross Profit for the Fourth Quarter 2023 and Fourth Quarter...

Continue reading

Rush Street Interactive Announces Fourth Quarter 2024 and Full Year 2024 Results

– Fourth Quarter Revenue of $254 Million, up 31% Year-over-Year –– Full Year 2024 Revenue of $924 Million, up 34% –– Fourth Quarter and Full Year Net Income of $6.5 Million and $7.2 Million, respectively –– Fourth Quarter Adjusted EBITDA of $30.6 Million, up 166% Year-over-Year –– Full Year Adjusted EBITDA of $92.5 Million, up 1,033% Year-over-Year –– Initiating Full Year 2025 Revenue Guidance of Between $1,010 and $1,080 Million and Adjusted EBITDA Guidance of Between $115 and $135 Million – CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced financial results for the fourth quarter and full year ended...

Continue reading

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Full Year 2024 Total Revenues of $491.7 Million, Marking Another Year of Record Growth Full Year 2024 Total Revenues Grew 23.5% YoY, Driven by Strong Commercial Performance Q4 2024 Net Product Revenue of $141.8 Million, Fueled by Sustained Organic Growth of FIRDAPSE® and Continued Market Adoption of AGAMREE® Pursuing Strategic Investments to Expand Market Presence and Accelerate Growth Full Year 2025 Total Revenues Expected to be Between $545 Million and $565 Million, Reflecting Confidence in Continued Growth Momentum Conference Call and Webcast to be Held on February 27, 2025, at 8:30 AM ET CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for the fourth quarter and full year 2024 and provided a business update. “Our record...

Continue reading

Applied Optoelectronics Reports Fourth Quarter and Full Year 2024 Results

SUGAR LAND, Texas, Feb. 26, 2025 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, telecom and fiber-to-the-home (FTTH) markets, today announced financial results for its fourth quarter and full year ended December 31, 2024. “We are pleased to have generated a solid quarter, driven by strength in both our datacenter and CATV businesses,” said Dr. Thompson Lin, AOI’s Founder, President and Chief Executive Officer. “We continued to see increasing orders in our datacenter business and believe we have solid momentum going forward. We saw a significant increase in our CATV business due to a ramp in orders for our 1.8 GHz amplifier products, which resulted in revenue growth that more than doubled sequentially....

Continue reading

MYR Group Inc. Announces Fourth Quarter and Full Year 2024 Results

Board Approves New $75 Million Share Repurchase Program THORNTON, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR” or the “Company”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced today its fourth quarter and full year 2024 financial results, and a new share repurchase program (“Repurchase Program”). Fourth Quarter 2024 HighlightsQuarterly revenues of $829.8 million Quarterly net income of $16.0 million, or $0.99 per diluted share Quarterly EBITDA of $45.5 millionFull Year 2024 HighlightsFull-year revenues of $3.36 billion Full-year net income of $30.3 million, or $1.83 per diluted share Full-year EBITDA of $117.8 million Backlog of $2.58 billionManagement...

Continue reading

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025 Anticipate completing enrollment in the PROGRESS-AD Phase 2 clinical trial of AL101/GSK4527226 in participants with early Alzheimer’s disease by mid-2025 Applying Alector Brain Carrier to advance therapeutic candidates, including those targeting amyloid beta and replacing GCase $413.4 million in cash, cash equivalents and investments provide runway through 2026 Management to host conference call and webcast today at 4:30 p.m. ET/1:30 p.m. PT SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today reported fourth quarter and full year 2024 financial...

Continue reading

Greif Reports Fiscal First Quarter 2025 Results

DELAWARE, Ohio, Feb. 26, 2025 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today announced fiscal first quarter 2025 results. Fiscal First Quarter 2025 Financial Highlights: (all results compared to the first quarter of 2024 unless otherwise noted)Net income decreased 87.2% to $8.6 million or $0.15 per diluted Class A share compared to net income of $67.2 million or $1.17 per diluted Class A share, primarily due to a non-recurring income tax benefit of $48.1 million in the prior year quarter. Net income, excluding the impact of adjustments(1), decreased 69.1% to $22.5 million or $0.39 per diluted Class A share compared to net income, excluding the impact of adjustments, of $72.7 million or $1.27 per diluted Class A share. Adjusted EBITDA(2) increased 5.9% to...

Continue reading

Matterport Announces Fourth Quarter 2024 Financial Results, with Over 50 Billion in Square Feet Under Management, up 33%, and Total Subscription Revenue up 14%, Year-over-Year

Record full year subscription revenue of $99.6 million, up 14% year-over-year Q4 annualized recurring revenue (ARR) grows to $104.2 million Record full year total revenue of $169.7 million Total subscribers grew to 1.2 million, up 23% year-over-yearSUNNYVALE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Matterport, Inc. (Nasdaq: MTTR) (“Matterport” or the “Company”), the leading spatial data company driving the digital transformation of the built world, today announced financial results for the quarter and year ended December 31, 2024. “I’m pleased to share our fourth quarter and full year 2024 results, highlighting our continued success driving efficient growth while doubling down on innovation. Total square feet digitized and managed reached a significant company milestone of 50.7 billion, up 33% year-over-year, with annual recurring...

Continue reading

Teladoc Health Reports Full Year and Fourth Quarter 2024 Results

PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 (“Full Year 2024”) and three months ended December 31, 2024 (“Fourth Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 (“Full Year 2023”) and three months ended December 31, 2023 (“Fourth Quarter 2023”). Full Year and Fourth Quarter 2024 HighlightsFull Year 2024 revenue of $2,569.6 million, down 1% year-over-year, and Fourth Quarter 2024 revenue of $640.5 million, down 3% year-over-year Full Year 2024 net loss of $1,001.2 million, or $5.87 per share, and Fourth Quarter 2024 net loss of $48.4 million, or $0.28 per share Full Year 2024 adjusted EBITDA of...

Continue reading

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Conference call to provide corporate updates today at 4:30 pm ET2024 revenues of $286M, +43% v. 2023; 4Q 2024 revenues of $77M, +31% v. 4Q 2023 2024 net income of $28M; Non-GAAP net income of $68M 4Q 2024 net income of $7M; Non-GAAP net income of $23M Reduced debt principal by $236M; remaining convertible debt of $36M Year-end 2024 cash, cash equivalents and investments of $203M Advanced pipeline:Reported primary endpoint of INHALE-1 for Afrezza in pediatrics Progressed MNKD-101 to Global Phase 3 Completed Phase 1 of MNKD-201DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today reported financial results for the quarter and year ended December 31, 2024, and provided a business update. “Throughout 2024, we accomplished the milestones we outlined at the beginning...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.